Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

C-Suite Perspectives

Leadership Lessons from Johnson & Johnson CEO Joaquin Duato

16 Jun 2025

Description

Science and technology will bring more change to health care over the next decade than we saw in the past century, says Joaquin Duato, Chairman and CEO, Johnson & Johnson, and a 2025 Distinguished Leadership Award honoree. What drives his confidence, and how is the company creating this future?     Join David K. Young and Duato to discover what he has learned in 36 years at J&J, how the company innovates in science and technology, and how the company supports employees and communities.  This Leadership in Challenging Times discussion is featured as a C-Suite Perspectives podcast and a special CED Policy Watch Webcast. Leadership in Challenging Times features timely and insightful discussions with the outstanding CEOs who are recipients of CED's Distinguished Leadership Awards. Business leader honorees discuss the unprecedented challenges facing the nation and how they are helping chart a path forward for both their companies and communities in which they operate.      (04:08) Leadership Philosophy and Company Culture (06:48) Secrets to Johnson & Johnson's Longevity (09:11) Transforming Health Care with Science and Technology (12:09) Investment Strategies in Health Care Innovation (15:53) Advancing Technology and AI at Johnson & Johnson (18:38) Addressing the Global Health Care Workforce Shortfall (19:41) Ensuring Access to Health Care for Underserved Communities   For more from The Conference Board:  CED Announces Recipients of Its 2025 Distinguished Leadership Awards  CED Distinguished Leadership Awards Celebration 

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.